An interventional study of AI assisted echocardiography in Rheumatic Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati. Not yet recruiting at 1 site in Uganda. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Rheumatic Heart Disease by Children's Hospital Medical Center, Cincinnati — 7 open to participants now, 7 under way, 2 of them phase 3. Rheumatic Heart Disease · Children's Hospital Medical Center, Cincinnati.
Among the 13 studies in Rheumatic Heart Disease by Children's Hospital Medical Center, Cincinnati, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is one of 4 that started in 2026, is one of 7 with no phase, and was the 8th registered.
62 studies on the registry are indexed under Rheumatic Heart Disease; 26 are open to participants now.
Browse Rheumatic Heart Disease studies →7 of the 13 studies in Rheumatic Heart Disease by Children's Hospital Medical Center, Cincinnati are open now, in 2 countries. Recruiting first, the newest first:
Children's Hospital Medical Center, Cincinnati · Sites in Uganda
Ages 5–20
Children's Hospital Medical Center, Cincinnati · Sites in Uganda
Ages 5+
Children's Hospital Medical Center, Cincinnati · Sites in Uganda
Ages 5–8 · Healthy volunteers
Children's Hospital Medical Center, Cincinnati · Sites in Uganda
Ages 5–8
Children's Hospital Medical Center, Cincinnati · Sites in Uganda
Healthy volunteers
By country, each count listing its studies:
Of the 11 Rheumatic Heart Disease studies recruiting now, 5 (45%) set no upper age limit and 5 (45%) stop at 75 or younger; 8 take children under 18; 4 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2022; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 62 is below the median of 221 across 37 interventional studies indexed under Rheumatic Heart Disease.
Median enrollment 629 across the 10 interventional studies, 1,423 across the 3 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Children's Hospital Medical Center, Cincinnati is the lead sponsor of 673 studies on the registry; 129 are open to participants now.
Of its 57 completed or terminated interventional studies of FDA-regulated products, 32 (56%) have results posted.
1 of the studies in Rheumatic Heart Disease by Children's Hospital Medical Center, Cincinnati that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05783375Children's Hospital Medical Center, CincinnatiAccelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda | 2027-01-31 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Rheumatic Heart Disease by Children's Hospital Medical Center, Cincinnati, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main goal of this project is to see if RADAR (Rapid AI-assisted Detection and Analysis of Rheumatic heart disease), which is a machine and deep-learning AI model, can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test whether RADAR can screen as accurately-or more accurately-than current methods, and whether it can be used effectively in different low-resource settings. The aim is to show that RADAR could be adopted and used widely around the world.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
In the Standard non-AI Echocardiography arm, participants will receive the current standard of care under the ADUNU program, which includes a single parasternal long-axis view with black-and-white and color Doppler imaging. Providers have been trained to recognize mitral regurgitation greater than 1.5 or 2 cm, any aortic insufficiency, qualitatively reduced left ventricular systolic function, and pericardial effusion. Detection of any of these findings constitutes a screen positive, prompting referral for a confirmatory echocardiogram.
In the RADAR Echocardiography arm, participants will undergo AI-assisted screening according to the well-established RADAR protocol including the same image acquisition protocol but interpreted by the tablet-based software based on two independent AI algorithms 1) RHD positive or negative and 2) mitral regurgitation jet length. Positive findings from either algorithm constitutes a screen positive. Providers may also refer for other concerns.
Diagnostic Test: AI assisted echocardiography
Continue standard of care with AI-assisted echocardiography
Accuracy of Provider RHD Screening
The number of correctly identified (positive or negative) screenings divided by the total number of exams.
Time frame: 1 year
Interpretation Sensitivity
The number of correctly identified positive screening exams divided by the sum of correctly identified positive and incorrectly identified negative exams.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Jun 2028, 19 months later.
Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Nov 2026, on Oct 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital Medical Center, Cincinnati →